IP Library Granted Patent US 8,923,943
Granted Patent B2
US 8,923,943 · App. 13/793,964 · Granted Dec 30, 2014

Method for spectrophotometric blood oxygenation monitoring

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,923,943
App. No.
13/793,964
Granted
Dec 30, 2014
Kind
B2
Abstract

According to the present invention, a method and apparatus for non-invasively determining the blood oxygen saturation level within a subject's tissue is provided. The method includes the steps of: a) providing a spectrophotometric sensor operable to transmit light into the subject's tissue, and to sense the light; b) detecting light after passage through the subject's tissue using the sensor, and producing initial signal data from the light sensed; c) calibrating the sensor to that particular subject using the initial signal data, thereby accounting for the specific physical characteristics of the particular subject's tissue being sensed; and d) using the calibrated sensor to determine the blood oxygen parameter value within the subject's tissue.

Claims (20)

1. A method for non-invasively determining a blood oxygen parameter value of a subject's tissue, comprising the steps of:

providing a spectrophotometric sensor operable to transmit light into the subject's tissue, and to sense the light;

detecting light after passage through the subject's tissue using the sensor, and producing initial signal data from the light sensed;

calibrating the sensor to that particular subject using the initial signal data, thereby accounting for the specific physical characteristics of the particular subject's tissue being sensed; and

subsequent to calibrating the sensor, using the calibrated sensor to determine the blood oxygen parameter value within the subject's tissue.

2. The method of claim 1 , wherein the blood oxygen parameter is oxyhemoglobin.

3. The method of claim 1 , wherein the blood oxygen parameter is deoxyhemoglobin.

4. The method of claim 3 , wherein the calibrating step includes processing the signal data to consider pigmentation of the subject's tissue.

5. The method of claim 4 , wherein the processing step includes the use of absorption coefficients for pigmentation in the subject's tissue.

6. The method of claim 1 , wherein the step of determining the blood oxygen parameter value within the subject's tissue comprises processing signal data other than the initial signal data.

7. An apparatus for non-invasively determining a blood oxygen saturation level of the microvasculature within a subject's tissue, the apparatus comprising:

a spectrophotometric sensor operable to transmit light into the subject's tissue, to detect the light after passage through the subject's tissue using the sensor, and to produce initial signal data from the light sensed;

a processor adapted to calibrate the sensor to that particular subject using the initial signal data, thereby accounting for the specific physical characteristics of the particular subject's tissue being sensed, and adapted to use the calibrated sensor to determine the blood oxygen saturation level within the subject's tissue.

8. The apparatus of claim 7 , wherein the physical characteristics of the subject's tissue include pigmentation of skin and tissue disposed below the skin.

9. The apparatus of claim 8 , wherein the processor is adapted to create absorption coefficients representative of the pigmentation of the skin and tissue below the skin.

10. The apparatus of claim 9 , wherein the processor is adapted to determine one or more calibration constants using the absorption coefficients for pigmentation, which calibration constants are used to determine the blood oxygen saturation level within the subject's tissue.

11. The apparatus of claim 7 , wherein the sensor is adapted to produce initial signal data that is attributable to non-pulsatile blood flow within the microcirculation of the subject's tissue.

12. The apparatus of claim 7 , wherein the processor is adapted to determine the blood oxygen saturation level within the subject's tissue using signal data other than the initial signal data.

13. The apparatus of claim 7 , wherein the processor is adapted to determine the concentration of at least one of oxyhemoglobin and deoxyhemoglobin of the microvasculature within the subject's tissue using the calibrated sensor.

14. The apparatus of claim 7 , wherein the spectrophotometric sensor includes at least one light source and at least one light detector, wherein the light source is operable to transmit light along a plurality of wavelengths into the subject's tissue, and the light detector is operable to detect light from the light source after the light has traveled through the subject's tissue.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2025
From: EDWARDS LIFESCIENCES CORPORATION; EDWARDS LIFESCIENCES LLC; EDWARDS LIFESCIENCES SÀRL; EDWARDS LIFESCIENCES HOLDING B.V.
To: BD SWITZERLAND SARL
Reel/Frame 072920/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2019
From: CAS MEDICAL SYSTEMS, INC.
To: EDWARDS LIFESCIENCES CORPORATION
Reel/Frame 050635/0654 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2018
From: BENNI, PAUL B.
To: CAS MEDICAL SYSTEMS, INC.
Reel/Frame 047602/0158 →
RELEASE OF SECURITY INTEREST Recorded May 16, 2018
From: SOLAR CAPITAL LTD.
To: CAS MEDICAL SYSTEMS, INC.
Reel/Frame 045823/0342 →
PATENT SECURITY AGREEMENT Recorded Jun 30, 2016
From: CAS MEDICAL SYSTEMS, INC.
To: SOLAR CAPITAL LTD.
Reel/Frame 039221/0004 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 16, 2016
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS RETIRING AGENT
To: SOLAR CAPITAL LTD., AS SUCCESSOR AGENT
Reel/Frame 038711/0067 →
SECURITY INTEREST Recorded Mar 28, 2016
From: CAS MEDICAL SYSTEMS, INC.
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC (AS SUCCESSOR-IN-INTEREST TO GENERAL ELECTRIC CAPITAL CORPORATION), AS AGENT
Reel/Frame 038115/0439 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 15, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037112/0159 →
SECURITY INTEREST Recorded Jun 27, 2014
From: CAS MEDICAL SYSTEMS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 033247/0323 →